Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC

Aim: Intravesical Bacillus Calmette–Guérin (BCG) is the standard therapy for non-muscle invasive bladder cancer (NMIBC); however, many patients experience recurrence or progression. We examined how urinary immune signals and the urinary microbiome change across BCG and are related to outcomes. Metho...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Yuki Oda, Makito Miyake, Nobutaka Nishimura, Takuto Shimizu, Takuya Owari, Kota Iida, Yasushi Nakai, Nobumichi Tanaka, Kiyohide Fujimoto
Format:	Artigo
Sprog:	Inglês
Udgivet:	Open Exploration Publishing Inc. 2026-04-01
Serier:	Exploration of Targeted Anti-tumor Therapy
Fag:	bacillus calmette–guérin (bcg) therapy non-muscle invasive bladder cancer urinary immune profiling urinary microbiome dynamics firmicutes/bacteroidetes ratio progression-free survival
Online adgang:	https://www.explorationpub.com/uploads/Article/A1002365/1002365.pdf
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!